A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

Clinical trial NCT03662568 · COMPLETED

Trial details

NCT number: NCT03662568
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2018-06-26
Primary completion: 2018-07-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.